Psychoactive medications (PM) are frequently administered in the intensive care unit (ICU) to provide comfort. Interventions focused on preventing their continuation after the acute phase of illness are needed.
Objective:
To determine the frequency that patients with ICU-initiated PM are continued upon ICU and hospital discharge.
Methods:
This single-center, prospective, observational study assessed consecutive adult ICU patients who received scheduled PM. Frequency of PM continued at ICU and hospital discharge was recorded. The patient’s primary treatment team was contacted by the pharmacist within 72 hours of ICU discharge to establish rationale for continued use or to suggest discontinuation.
Results:
Of the 60 patients included, 72% were continued on PM at ICU discharge and 30% at hospital discharge. The pharmacist contacted 40% of treatment teams after ICU discharge and intervention resulted in PM discontinued in 50% of patients. Post ICU discharge, the indication of 41% of patients’ PM was unknown by the non-ICU care team or incorrect. Medical ICU patients or those transferred to an outside facility were more likely remain on PM at hospital discharge.
Conclusion:
PM are frequently continued during transitions of care and often without knowledge of the initial indication. Future studies should establish effective PM stewardship methods.
DevlinJWSkrobikYGelinasC, et al.Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46(9):e825–e873.
2.
GagnonDJKovacicNFraserGL. Agitation and comfort in the intensive care unit. In: Critical Care Pharmacotherapy. Lenexa: American College of Clinical Pharmacy; 2016. 161–185.
3.
GagnonDJRikerRGlisicEK, et al.Transition from dexmedetomidine to enteral clonidine for ICU sedation: a pilot study. Pharmacotherapy. 2015;35(3):251–259.
4.
GagnonDJFontaineGVSmithKE, et al.Valproate for agitation in critically ill patients: a retrospective study. J Crit Care. 2017;37:119–125.
5.
GagnonDJFontaineGVRikerRR, et al.Repurposing valproate, enteral clonidine, and phenobarbital for comfort in adult ICU patients: a literature review with practical considerations. Pharmacotherapy. 2017;37(10):1309–1321.
6.
FraserGLRikerRR. Phenobarbital provides effective sedation for a select cohort of adult ICU patients intolerant of standard treatment: a brief report. Hosp Pharm. 2006;41(1):17–23.
7.
PatelRPGambrellBASperoffT, et al.Delirium and sedation in the intensive care unit (ICU): survey of behaviors and attitudes of 1,384 healthcare professionals. Crit Care Med. 2009;37(3):825–832.
8.
YassinSMTerblancheMYassinJ, et al.A web-based survey of United Kingdom sedation practice in the intensive care unit. J Crit Care. 2014;30:436. e1–e6.
9.
MehtaSMcCullaghIBurryL. Current sedation practices: lessons learned from international surveys. Crit Care Clin. 2009;25(3):471–488.
10.
EgerodIChristensenBVJohansenL. Trends in sedation practices in Danish intensive care units in 2003: a national survey. Intensive Care Med. 2006;32(1):60–66.
11.
DevlinJWBhatSRobertsRJ, et al.Current perceptions and practices surrounding the recognition and treatment of delirium in the intensive care unit: a survey of 250 critical care pharmacists from eight states. Ann Pharmacother. 2011;45(10):1217–1229.
12.
GirardTDExlineMCCarsonSS, et al.Haloperidol and ziprasidone for treatment of delirium in critical illness. N Engl J Med. 2018;379(26):2506–2516.
13.
JasiakKDMiddletonEACamamoJM, et al.Evaluation of discontinuation of atypical antipsychotics prescribed for ICU delirium. J Pharm Pract. 2013;26(3):253–256.
14.
KramBLKramSJBrooksKR. Implications of atypical antipsychotic prescribing in the intensive care unit. J Crit Care. 2015;30(4):814–818.
15.
D’AngeloRGRincavageMTataAL, et al.Impact of an antipsychotic discontinuation bundle during transitions of care in critically ill patients. J Intensive Care Med. 2019;34(1):40–47.
16.
TomichekJEStollingsJLPandharipandePP, et al.Antipsychotic prescribing patterns during and after critical illness: a prospective cohort study. Crit Care. 2016;20(1):378.
17.
ScalesDCFischerHDBiermanAS, et al.Unintentional continuation of medications intended for acute illness after hospital discharge: a population-based cohort study. J Gen Intern Med. 2016;31(2):196–202.
18.
FlurieRWGonzalesJPTataAL, et al.Hospital delirium treatment: continuation of antipsychotic therapy from the intensive care unit to discharge. Am J Health Syst Pharm. 2015;72(23 suppl 3):S133–S139.
19.
FarrokhSCastleACHeavnerM, et al.Continuation rate of atypical antipsychotics after discharge when initiated in the intensive care unit. J Pharm Pract. 2017;30(3):342–346.
20.
MarshallJHerzigSHowellMD, et al.Antipsychotic utilization in the intensive care unit and in transitions of care. J Crit Care. 2016;33:119–124.
21.
KramBLSchultheisJMKramSJ, et al.A pharmacy-based electronic handoff tool to reduce discharge prescribing of atypical antipsychotics initiated in the intensive care unit: a quality improvement initiative. J Pharm Pract. 2019;32(4):434–441.
22.
MartzCPetersMSwiderekJ, et al.Evaluation of a pharmacist-driven medication discontinuation protocol in an intensive care unit. Crit Care Med. 2017:46(suppl 1).
23.
RoweASHamiltonLACurtisRA, et al.Risk factors for discharge on a new antipsychotic medication after admission to an intensive care unit. J Crit Care. 2015;30(6):1283–1286.
24.
GilbertBMoralesJRSearcyRJ, et al.Evaluation of neuroleptic utilization in the intensive care unit during transitions of care. J Intensive Care Med. 2017;32(2):158–162.
25.
FraserLALiuKNaylorK, et al.Falls and fractures with atypical antipsychotic medication use: a population-based cohort study. JAMA Intern Med. 2015;175(3):450–452.
26.
PrattNRougheadEERamsayE, et al.Risk of hospitalization for hip fracture and pneumonia associated with antipsychotic prescribing in the elderly. Drug Saf. 2011;34(7):567–575.
27.
ZemrakWRKennaGA. Association of antipsychotic and antidepressant drugs with Q-T interval prolongation. Am J Health Syst Pharm. 2008;65(11):1029–1038.
28.
MeulendijksDMannesseCKJansenPAF, et al.Antipsychotic-induced hyponatraemia: a systematic review of the published evidence. Drug Saf. 2010;33(2):101–114.
29.
HwangYJDixonSNReissJP, et al.Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults. Ann Intern Med. 2014;161(4):242–248.
30.
LohKPRamdassSGarbJL, et al.Long-term outcomes of elders discharged on antipsychotics. J Hosp Med. 2016;11(8):550–555.
31.
ParkYBatemanBTKimDH, et al.Use of haloperidol versus atypical antipsychotics and risk of in-hospital death in patients with acute myocardial infarction: cohort study. BMJ. 2018;360:k1218.
32.
WangMTTsaiCLLinCW, et al.Association between antipsychotic agents and risk of acute respiratory failure in patients with chronic obstructive pulmonary disease. JAMA Psychiatry. 2017;74(3):252–260.
33.
PisaniMAAraujoKLVan NessPH, et al.A research algorithm to improve detection of delirium in the intensive care unit. Crit Care. 2006;10(4):R121.
34.
BurkRSGrapMJMunroCL, et al.Agitation onset, frequency, and associated temporal factors in critically ill adults. Am J Crit Care. 2014;23(4):296–304.
35.
BurkRSGrapMJMunroCL, et al.Predictors of agitation in critically ill adults. Am J Crit Care. 2014;23(5):414–423.
36.
O’ConnorHAl-QadheebNSWhiteAC, et al.Agitation during prolonged mechanical ventilation at a long-term acute care hospital: risk factors, treatments, and outcomes. J Intensive Care Med. 2014;29(4):218–224.
37.
PavlovAMuravyevRAmoateng-AdjepongY, et al.Inappropriate discharge on bronchodilators and acid-blocking medications after ICU admission: importance of medication reconciliation. Respir Care. 2014;59(10):1524–1529.
38.
ScalesDCFischerHDLiP, et al.Unintentional continuation of medications intended for acute illness after hospital discharge: a population-based cohort study. J Gen Intern Med. 2015;31(2):196–202.
39.
CaroffSNMannSCCampbellEC. Atypical antipsychotics and neuroleptic malignant syndrome. Psychiatr Ann. 2000;30(5):314–321.
40.
RayWAChungCPMurrayKT, et al.Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360(3):225–235.
41.
BrodieMJDichterMA. Antiepileptic drugs. N Engl J Med. 1996;334(3):168–175.
42.
StollingsJLBloomSLWangL, et al.Critical care pharmacists and medication management in an ICU recovery center. Ann Pharmacother. 2018;52(8):713–723.
